Stay updated on Tipifarnib and Alpelisib in R/M HNSCC Clinical Trial
Sign up to get notified when there's something new on the Tipifarnib and Alpelisib in R/M HNSCC Clinical Trial page.

Latest updates to the Tipifarnib and Alpelisib in R/M HNSCC Clinical Trial page
- Check4 days agoChange DetectedUpdated page version from v3.0.1 to v3.0.2 and removed the 'Back to Top' element.SummaryDifference0.2%
- Check11 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.2%
- Check18 days agoChange DetectedThe web page has been updated to include new drug information for Alpelisib and related medical topics, while removing some previous location details and references to certain neoplasms and drugs.SummaryDifference4%
- Check25 days agoChange DetectedThe page has removed the 'Last Update Posted (Estimated)' section and replaced it with a more definitive 'Last Update Posted' label.SummaryDifference0.0%
- Check33 days agoChange DetectedThe webpage has been updated with new dates and a revised version number, while some previous dates and information about expanded access have been removed. Additionally, the location name has been standardized from 'Saint Louis' to 'St. Louis'.SummaryDifference2%
- Check40 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.1%
Stay in the know with updates to Tipifarnib and Alpelisib in R/M HNSCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tipifarnib and Alpelisib in R/M HNSCC Clinical Trial page.